Haemonetics (HAE) Net Cash Flow (QoQ) (2009 - 2026)
Haemonetics (HAE) Net Cash Flow (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Haemonetics | 3.50 Bn | 3.26 Bn | 198.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -277.18% |
| Dec 27, 2025 | 1,437.57% |
| Sep 27, 2025 | 123.83% |
| Jun 28, 2025 | -7.08% |
| Mar 29, 2025 | -160.68% |
| Dec 28, 2024 | 156.28% |
| Sep 28, 2024 | -129.54% |
| Jun 29, 2024 | 1,439.06% |
| Mar 30, 2024 | 92.20% |
| Dec 30, 2023 | -339.53% |
| Sep 30, 2023 | 1,970.56% |
| Jul 1, 2023 | -94.62% |
| Apr 1, 2023 | 375.68% |
| Dec 31, 2022 | -171.87% |
| Oct 1, 2022 | 176.45% |
| Jul 2, 2022 | -259.92% |
| Apr 2, 2022 | -44.87% |
| Jan 1, 2022 | 128.97% |
| Oct 2, 2021 | 202.40% |
| Jul 3, 2021 | -468.13% |